Michael M. Thornton - Jan 30, 2023 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Chief Technology Officer
Signature
/s/ Michael M. Thornton by Mark Busch, attorney-in-fact
Stock symbol
NDRA
Transactions as of
Jan 30, 2023
Transactions value $
$0
Form type
4
Date filed
2/1/2023, 07:30 PM
Previous filing
Dec 13, 2022
Next filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NDRA Stock Options Award $0 +68.1K $0.00 68.1K Jan 30, 2023 Common Stock 68.1K $4.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.